PredOmix

PredOmix is an Indian health-technology company focused on the early detection of cancer through a combination of metabolomics and artificial intelligence. The company's primary offering, Onco-Life, is a multi-cancer early detection (MCED) blood test designed to identify several types of cancer, including those specific to women, with high sensitivity and specificity. By analyzing metabolic signatures in the blood, PredOmix's platform can detect malignancies at early stages when they are most treatable, often before symptoms appear. The company leverages advanced data science and mass spectrometry to provide non-invasive diagnostic solutions that aim to reduce cancer mortality rates globally. Headquartered in Gurugram, PredOmix is expanding its testing capabilities to include cancers prevalent in men, such as prostate and liver cancer.